| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in therapy of locally advanced lung cancer
|
Livingston, R.B
|
|
2001
|
|
9-10 |
p. 558-
1 p.
|
artikel
|
| 2 |
Author index
|
|
|
2001
|
|
9-10 |
p. 574-575
2 p.
|
artikel
|
| 3 |
Breast cancer chemoprevention: current clinical practice and future direction
|
Bevers, T.B
|
|
2001
|
|
9-10 |
p. 559-564
6 p.
|
artikel
|
| 4 |
Clinical research today and tomorrow
|
Freireich, E.J
|
|
2001
|
|
9-10 |
p. 572-573
2 p.
|
artikel
|
| 5 |
Cytokine deregulation in cancer
|
Kurzrock, R
|
|
2001
|
|
9-10 |
p. 543-547
5 p.
|
artikel
|
| 6 |
Keyword index
|
|
|
2001
|
|
9-10 |
p. 576-580
5 p.
|
artikel
|
| 7 |
Minimally invasive surgery in breast cancer treatment
|
Singletary, S.E
|
|
2001
|
|
9-10 |
p. 510-514
5 p.
|
artikel
|
| 8 |
Myeloma: what have we learned?
|
Bergsagel, D.E
|
|
2001
|
|
9-10 |
p. 548-549
2 p.
|
artikel
|
| 9 |
New biology and therapies in soft tissue sarcomas
|
Antman, K.H
|
|
2001
|
|
9-10 |
p. 553-557
5 p.
|
artikel
|
| 10 |
Post-mastectomy irradiation: the continuing controversy
|
McNeese, M.D.
|
|
2001
|
|
9-10 |
p. 519-523
5 p.
|
artikel
|
| 11 |
Progress in CLL, chemotherapy, antibodies and transplantation
|
Keating, M.J
|
|
2001
|
|
9-10 |
p. 524-528
5 p.
|
artikel
|
| 12 |
Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy
|
Cox, J.D
|
|
2001
|
|
9-10 |
p. 516-518
3 p.
|
artikel
|
| 13 |
Recent advances in treatment of multiple myeloma and Waldenström’s macroglobulinemia
|
Alexanian, R
|
|
2001
|
|
9-10 |
p. 550-552
3 p.
|
artikel
|
| 14 |
ST1571: a paradigm for clinical trials of molecularly targeted agents
|
Druker, B.J
|
|
2001
|
|
9-10 |
p. 529-530
2 p.
|
artikel
|
| 15 |
The role of the biostatistician in cancer research
|
Gehan, E.A.
|
|
2001
|
|
9-10 |
p. 502-509
8 p.
|
artikel
|
| 16 |
The role of the surgical oncologist in multidisciplinary reearch (NOTE)
|
R.E., Pollock
|
|
2001
|
|
9-10 |
p. 515-
1 p.
|
artikel
|
| 17 |
The roles of adoptive and active forms of immunotherapy in the cure of children suffering from acute lymphoid leukemia: a) underestimation of active immunotherapy benefit, b) its immunogenetic indications to select sensitive patients, hence prevent chemotherapy’s late effects
|
Mathé, G.
|
|
2001
|
|
9-10 |
p. 531-542
12 p.
|
artikel
|
| 18 |
Translational research – traffic on the bridge
|
Bast Jr., R.C
|
|
2001
|
|
9-10 |
p. 565-571
7 p.
|
artikel
|
| 19 |
Triumphs and challenges in oncology
|
Freireich, E.J
|
|
2001
|
|
9-10 |
p. 501-
1 p.
|
artikel
|
Tijdschrift beschrijving